These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38373256)

  • 41. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder.
    Soeiro-de-Souza MG; Salvadore G; Moreno RA; Otaduy MC; Chaim KT; Gattaz WF; Zarate CA; Machado-Vieira R
    Neuropsychopharmacology; 2013 Feb; 38(3):468-75. PubMed ID: 23072837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
    Brandt AS; Unschuld PG; Pradhan S; Lim IA; Churchill G; Harris AD; Hua J; Barker PB; Ross CA; van Zijl PC; Edden RA; Margolis RL
    Schizophr Res; 2016 Apr; 172(1-3):101-5. PubMed ID: 26925800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
    Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
    Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of
    Nakahara T; Tsugawa S; Noda Y; Ueno F; Honda S; Kinjo M; Segawa H; Hondo N; Mori Y; Watanabe H; Nakahara K; Yoshida K; Wada M; Tarumi R; Iwata Y; Plitman E; Moriguchi S; de la Fuente-Sandoval C; Uchida H; Mimura M; Graff-Guerrero A; Nakajima S
    Mol Psychiatry; 2022 Jan; 27(1):744-757. PubMed ID: 34584230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre
    Egerton A; Broberg BV; Van Haren N; Merritt K; Barker GJ; Lythgoe DJ; Perez-Iglesias R; Baandrup L; Düring SW; Sendt KV; Stone JM; Rostrup E; Sommer IE; Glenthøj B; Kahn RS; Dazzan P; McGuire P
    Mol Psychiatry; 2018 Nov; 23(11):2145-2155. PubMed ID: 29880882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF
    Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia.
    Gallinat J; McMahon K; Kühn S; Schubert F; Schaefer M
    Schizophr Bull; 2016 Mar; 42(2):425-33. PubMed ID: 26333842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.
    Tarumi R; Tsugawa S; Noda Y; Plitman E; Honda S; Matsushita K; Chavez S; Sawada K; Wada M; Matsui M; Fujii S; Miyazaki T; Chakravarty MM; Uchida H; Remington G; Graff-Guerrero A; Mimura M; Nakajima S
    Neuropsychopharmacology; 2020 Mar; 45(4):632-640. PubMed ID: 31842203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential levels of prefrontal cortex glutamate+glutamine in adults with antisocial personality disorder and bipolar disorder: A proton magnetic resonance spectroscopy study.
    Smaragdi A; Chavez S; Lobaugh NJ; Meyer JH; Kolla NJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():250-255. PubMed ID: 30959086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia.
    Rowland LM; Kontson K; West J; Edden RA; Zhu H; Wijtenburg SA; Holcomb HH; Barker PB
    Schizophr Bull; 2013 Sep; 39(5):1096-104. PubMed ID: 23081992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation.
    Lewis CP; Port JD; Blacker CJ; Sonmez AI; Seewoo BJ; Leffler JM; Frye MA; Croarkin PE
    Transl Psychiatry; 2020 Apr; 10(1):119. PubMed ID: 32327639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia.
    Griffiths K; Smart SE; Barker GJ; Deakin B; Lawrie SM; Lewis S; Lythgoe DJ; Pardiñas AF; Singh K; Semple S; Walters JTR; Williams SR; Egerton A; MacCabe JH
    Schizophr Res; 2023 Oct; 260():152-159. PubMed ID: 37657282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
    Mouchlianitis E; Bloomfield MA; Law V; Beck K; Selvaraj S; Rasquinha N; Waldman A; Turkheimer FE; Egerton A; Stone J; Howes OD
    Schizophr Bull; 2016 May; 42(3):744-52. PubMed ID: 26683625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia.
    McQueen G; Sendt KV; Gillespie A; Avila A; Lally J; Vallianatou K; Chang N; Ferreira D; Borgan F; Howes OD; Barker GJ; Lythgoe DJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Schizophr Bull; 2021 Apr; 47(3):662-671. PubMed ID: 33398325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.
    Chiappelli J; Rowland LM; Notarangelo FM; Wijtenburg SA; Thomas MAR; Pocivavsek A; Jones A; Wisner K; Kochunov P; Schwarcz R; Hong LE
    Neuropsychopharmacology; 2018 Jul; 43(8):1706-1711. PubMed ID: 29728648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo.
    Hall MH; Jensen JE; Du F; Smoller JW; O'Connor L; Spencer KM; Öngür D
    Neuroimage; 2015 May; 111():186-91. PubMed ID: 25687595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of
    An L; Li S; Ferraris Araneta M; Johnson CS; Shen J
    Sci Rep; 2022 May; 12(1):8729. PubMed ID: 35610241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced insulin sensitivity may be related to less striatal glutamate: An
    Caravaggio F; Iwata Y; Plitman E; Chavez S; Borlido C; Chung JK; Kim J; Agarwal SM; Gerretsen P; Remington G; Hahn M; Graff-Guerrero A
    Eur Neuropsychopharmacol; 2018 Feb; 28(2):285-296. PubMed ID: 29269206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.